Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Neuroendocrine Tumors 111Pheochromocytoma 33Carcinoma, Neuroendocrine 33Pituitary Neoplasms 28Thyroid Cancer, Papillary 26Paraganglioma 26Adrenocortical Carcinoma 21Neoplasms 19Gastro-enteropancreatic neuroendocrine tumor 19Thyroid Neoplasms 17Adrenal Gland Neoplasms 16Multiple Endocrine Neoplasia Type 1 14Stomach Neoplasms 13Prostatic Neoplasms 13Pancreatic Neoplasms 13Carcinoid Tumor 13Sarcoma 12Lung Neoplasms 12Breast Neoplasms 12Thyroid Carcinoma, Anaplastic 11Adenoma, Islet Cell 11Small Cell Lung Carcinoma 10Ovarian Neoplasms 10Neuroblastoma 10Neoplasm Metastasis 10Colorectal Neoplasms 10Carcinoma, Hepatocellular 10Brain Neoplasms 10Meningioma 9Esophageal Neoplasms 9

Interventions

Thyrotropin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × DTC - Differentiated Thyroid Cancer × Endocrine × Clear all
NCT07287748 2025-12-31

A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer

Alpha Fusion Inc.

Phase 1 Recruiting
38 enrolled
EndocrineHead & Neck

DTC - Differentiated Thyroid Cancer

NCT06405217 2024-05-08

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
30 enrolled
EndocrineHead & Neck

DTC - Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡